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Gingivitis is a preventable disease characterised by inﬂammation of the gums due to the buildup of a microbial bioﬁlm at the
gingival margin. It is implicated as a precursor to periodontitis, a much more serious problem which includes associated bone loss.
Unfortunately, due to poor oral hygiene among the general population, gingivitis is prevalent and results in high treatment costs.
Consequently, the option of treating gingivitis using functional foods, which promote oral health, is an attractive one. Medicinal
mushrooms, including shiitake, have long been known for their immune system boosting as well as antimicrobial eﬀects; however,
they have not been employed in the treatment of oral disease. In the current study, the eﬀectiveness of shiitake mushroom extract
wascomparedtothatoftheactivecomponentintheleadinggingivitismouthwash,containingchlorhexidine,inanartiﬁcialmouth
model (constant depth ﬁlm fermenter). The total bacterial numbers as well as numbers of eight key taxa in the oral community
were investigated over time using multiplex qPCR. The results indicated that shiitake mushroom extract lowered the numbers of
some pathogenic taxa without aﬀecting the taxa associated with health, unlike chlorhexidine which has a limited eﬀect on all taxa.
1.Introduction
Gingivitis is one of the most prevalent infectious diseases
of humans, aﬀecting most of the population at some point
during their lives [1]. It is easily preventable by the removal
oftheplaquebioﬁlmbutoftenresultsinhightreatmentcosts
duetopoororalhygieneamongthegeneralpopulation.Gin-
givitis has long been implicated as a potential precursor to
periodontitis[2,3]andiscausedbythebuildupoftheplaque
bioﬁlm at the gingival margin. This in turn results in a shift
intheresidentmicrobiotaasaconsequenceofenvironmental
changes [4, 5]. The prevalence of Actinomyces spp., Lactoba-
cillus spp., Prevotella spp., and Fusobacterium nucleatum is
known to increase during gingivitis at the expense of Strepto-
coccus spp. [6–9]. This community shift causes inﬂammation
of the gingiva as part of the immune response [3, 10, 11].
The disease can be prevented and alleviated by the removal
of the plaque bioﬁlm and by the use of oral hygiene products
such as toothbrushes, toothpastes, and mouthwashes [12].
The constant depth ﬁlm fermenter (CDFF) has been used
previously to model the bacterial community shifts observed
during gingivitis and has also been employed to assess the
eﬀects of oral hygiene products [13, 14].
Medicinal mushrooms, including Lentinula edodes or
shiitake, have been used in Asia for centuries and have nu-
merous health beneﬁts. These range from their antioxidant
properties, to lowering cholesterol and blood pressure, anti-
tumor properties, and antibacterial and libido-enhancing
properties [15–18]. The health beneﬁts of shiitake mush-
rooms are thought to be so great that they have been2 Journal of Biomedicine and Biotechnology
incorporated into some foods in order to be delivered to the
population, creating functional foods including pork patties,
cereals, and cookies [16, 19, 20]. However, shiitake has not as
yet been assessed for its oral health beneﬁts.
In recent years, high-throughput culture-independent
quantitative methods have revolutionised the investigation
of bacterial community structure. These methods are now
being employed in the study of microbial communities in-
volved in both oral health and disease [21–23]. In the present
study, a set of assays developed previously was used to mon-
itor the bacterial community structure changes within an
in vitro gingivitis model and to assess the eﬀect of shiitake
mushroom extract and chlorhexidine, the leading agent used
in the treatment of gum disease [24], on these communities.
2.MaterialsandMethods
2.1. Saliva Collection. Healthy individuals with good oral
hygiene were asked to expectorate into a sterile centrifuge
tube up to a volume of 2mL. Saliva was collected from
20 individuals. The saliva samples were homogenised into
pooledsaliva,andglycerolwasaddedtoaﬁnalconcentration
of 10%v/v. The pooled saliva was dispensed into 1mL
aliquots and stored at −80◦C.
2.2. CDFF Gingivitis Model. In vitro bioﬁlms, representative
of plaque that forms at the gingival margin, were cultured
using a CDFF. The environmental conditions within the
CDFF were modiﬁed in order to mimic those found during
gingivitis,asdescribedpreviously[14].Brieﬂy,theCDFFwas
inoculated by 1mL of pooled saliva sample added to 500mL
artiﬁcial saliva medium [25] over 8 hours. The bioﬁlms were
cultured at 36◦C for one week. The CDFF was kept under
microaerophilic conditions using a gas mixture (2% O2;3 %
CO2; 95% N at 200 × 105 Pa) pumped into the chamber
through a ﬁltered inlet at a rate of 200cm3 min−1.A r t i ﬁ c i a l
saliva medium and artiﬁcial gingival crevicular ﬂuid [26]
were pumped into the chamber throughout the experiment
at a ﬂow rate of 0.72 litres day−1 and 0.072 litres day−1,r e -
spectively.
No antimicrobials were pumped into the CDFF during
the no treatment control (NTC) experiments. During the
chlorhexidine(CHX)andmushroomextract(MUSH)exper-
iments, 0.12% chlorhexidine and 2x low molecular weight
shiitake mushroom extract were pumped into the CDFF
from 80h and every 12 hours thereafter to mimic the use of
a mouthwash twice daily. Each pulse was pumped in at a rate
of 2mL min−1 for 5 minutes.
One pan, containing ﬁve disks, was removed aseptically
every 24 hours. The biomass of two disks was collected as de-
scribed previously [14] in duplicate. DNA extractions were
then performed on the biomass collected.
2.3. Low Molecular Weight Shiitake Mushroom Extract Prepa-
ration. The 2x low molecular weight mushroom extract was
prepared as described by Daglia et al. [27].
2.4. DNA Extraction Method. Total nucleic acids were ex-
tracted from all samples according to a previously described
protocol [28] using a bead-beating phenol: chloroform:
isoamyl alcohol (25:24:1) extraction followed by a 30%
PEG 6000 precipitation and 70% ethanol wash. This method
was found to be the least biased towards the extraction of
nucleic acids from Gram-negative organisms.
2.5. qPCR Method. Three triplex qPCR assays were designed
toenumeratefourorganismsassociatedwithgingivitis (Acti-
nomyces naeslundii, Fusobacterium nucleatum, Lactobacillus
casei,a n dPrevotella intermedia), three organisms associated
with oral health (Streptococcus sanguinis, Neisseria subﬂava,
and Veillonella dispar), one organism strongly implicated in
dental caries (Streptococcus mutans), and all organisms as
described previously [23]. The detection limits for each of
the single taxa were 20 cells and the number rose to 600 cells
for the universal assay.
2.6. Statistics. Data were normalised by transformation us-
ing log10. ANOVA analysis was used to test whether changes
between the treatments were signiﬁcant (signiﬁcant P ≤
0.005; and slightly signiﬁcant P<0.01).
3. Results
3.1. Saliva Community. The microbial community present
in the pooled saliva used as the inoculum for the CDFF
was analysed using qPCR. The numbers of each of the taxa
analysed are shown in Figure 1. The mean (n = 3) total
number of organisms per millilitre of pooled saliva was
found to be 1.01 (±0.41) × 109 (standard deviation is shown
in brackets). The speciﬁc taxa being investigated made up
3.75 × 108 of the organisms or 37.24% of the total. Of these
taxa, the most numerous were V. dispar (22.8%), followed by
N. subﬂava (12.1%) and F. nucleatum (1.8%), and the least
is L. casei (0.05%). Very low variation was observed between
the three saliva samples which were proﬁled.
3.2. Gingivitis CDFF Plaque Bioﬁlm Communities. The data
regarding the numbers of individual taxa analysed and the
total number of bacteria present over the course of the
treatment experiments is shown in Table 1.
3.2.1. No Treatment Control (NTC). There was little change
in total numbers of organisms present over time, the num-
bers increased from around 107 at the start to around 108
cells per disk up to 72 hours and remaining at this level
throughout the experiment. Numbers of L. casei, P. inter-
media, and A. naeslundii were very low throughout. Other
taxa increased over time (mainly between the 72h sampling
point and the 96h point) by 3 log10,f o re x a m p l e ,F. nucle-
atum (from 0.007% to 5.399%), V. dispar (from 0.072%
to 13.093%), and N. subﬂava (from 0.022% to 78.446%).
S. sanguinis increased by 0.5 log10 (0.139% to 0.379%).
S. mutans was not detected at any time points.
3.2.2. Chlorhexidine Treatment (CHX). As with the NTC
exper-iment, the total numbers of organisms remained
broadly steady over the experiment. Numbers of L. casei, and
P. intermedia,a n dA. naeslundii were found in similar levelsJournal of Biomedicine and Biotechnology 3
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Figure 1: Numbers of each of the taxa investigated in pooled saliva. Error bars represent the standard deviation (n = 3).
as with the NTC experiment. However, numbers of N. sub-
ﬂava only rose by 1log10 throughout the experiment (from
3.838% to 10.919%), number of V. dispar and S. sanguinis
remained similar (1.590% to 0.774%; 0.360% to 0.275%,
resp.), and F. nucleatum deceased by around 1log10 (from
0.026% to 0.001%). S. mutans was not detected at any time
points.
3.2.3. Mushroom Treatment (MUSH). Total numbers of or-
ganisms were found to be around 108 cells per disk for
the duration of the experiment. Numbers of L. casei, P. in-
termedia, and A. naeslundii were very low throughout. How-
ever, numbers of N. subﬂava rose by 3log10 (from 0.011%
to 54.374%) throughout the experiment, number of V. dis-
par rose by 6log10 (0.000002% to 8.556%) throughout the
experiment, and F. nucleatum remained steady (0.00001%
to 0.00009%). S. sanguinis n u m b e r sr o s eb y2l o g 10 (0.001%
to 1.841%) throughout the experiment. S. mutans was not
detected at any time points.
3.3. Comparison of Taxa Numbers between Treatments. P. in-
termedia, L. casei, and A. naeslundii numbers were found
in low numbers during all three of the treatments with no
signiﬁcantdiﬀerencesbetweentreatmentsatanytimepoints.
The numbers of N. subﬂava cells appeared to be lower
duringtheCHXtreatmentfrom72h;however,nosigniﬁcant
diﬀerencebetweentreatmentswasfounduntilthe168htime
point (NTC, P = 0.010; MUSH, P = 0.004) (Figure 2).
V. dispar cell numbers were found to be signiﬁcantly lower
during the CHX treatment at 96h, 120h, and 168h (P ≤
0.003, P ≤ 0.021, and P = 0.001, resp.) (Figure 2).
S. sanguinis numbers were signiﬁcantly higher during the
MUSH treatment than during the CHX treatment at time
points 48, 96, 120, and 168 hours (P = 0.047, P = 0.052,
P = 0.032, and P = 0.021, resp.) (Figure 2). Numbers
of F. nucleatum were found to be signiﬁcantly lowered by
the MUSH and CHX treatments from 96 hours onwards
(P ≤ 0.030)(Figure 2).Finally,examiningtheuniversalassay
cell numbers, the CHX experiment counts are signiﬁcantly
lowerthanthoseintheMUSHexperimentat48,96,120,and
168 hours (P = 0.010, P = 0.019, P = 0.044, and P = 0.022,
resp.) (Figure 2).
4. Discussion
4.1. Saliva Community. The bacterial community found in
salivary ﬂuid is composed of the amalgamation of the
communities found around the mouth. The predominant
taxa were found to be V. dispar, N. subﬂava, F. nucleatum,
A. naeslundii, and S. sanguinis. These taxa have all been
associated with healthy dental plaque bioﬁlms in previous
cultureindependentstudies[29,30].Thetonguecommunity
in healthy subjects has previously been found to comprise
mostly Streptococcus spp., Veillonella spp., and Actinomyces
spp. [31, 32]. A recent study looking into the unculturable
microbiotaofthetonguehasalsoidentiﬁedtheabovegenera,
along with a Lysobacter-type species as the predominant
organism found on the tongue [33].
Two studies using culture-independent molecular meth-
ods have shown that the dominant phyla most commonly
f o u n di ns a l i v aw e r eF i r m i c u t e s ,B a c t e r i o d e t e s ,P r o t e o b a c t e -
ria, Actinobacteria, and Fusobacteria, respectively [22, 34].
The multitriplex qPCR method showed a similar picture: the
Firmicutes were the dominant organisms, followed by Pro-
teobacteria, Fusobacteria, Actinobacteria, and Bacteriodetes.
4.2. CDFF Plaque Bioﬁlm Communities. Whilst the universal
assayconﬁrmedtotalcellsnumbersinthebioﬁlmstobehigh
in all of the CDFF experiments, some of the taxa investigated
were only detected in low levels including P. intermedia, L.
casei, S. mutans, and A. naeslundii. While Actinomyces spp.
are known to be one of the early colonizers in the formation4 Journal of Biomedicine and Biotechnology
Table 1: Numbers of each of the taxa investigated in bioﬁlms grown in the gingivitis CDFF over one week under various treatments: Control
(n = 2), Chlorhexidine (n = 4), and LMW mushroom (n = 2) pulsing.
Control
24h 48h 72h 96h 120h 144h 168h
F. nucleatum 4.68 (±0.71)
× 103
1.38 (±0.11)
× 103
5.39 (±0.41)
× 103
5.07 (±0.05)
× 105
2.99 (±1.82)
× 106
3.31 (±0.87)
× 106
6.26 (±0.30)
× 106
L. casei 6.20 (±4.81)
× 102
7.80 (±4.53)
× 102
7.80 (±4.53)
× 102
8.20 (±9.05)
× 102
9.10 (±9.76)
× 102
9.80 (±9.33)
× 102
9.00 (±10.7)
× 102
V. dispar 4.91 (±4.13)
× 104
2.29 (±2.18)
× 105
2.65 (±1.41)
× 106
7.83 (±3.74)
× 106
8.94 (±7.24)
× 106
8.28 (±3.96)
× 106
1.52 (±0.26)
× 107
N. subﬂava 1.52 (±0.72)
× 104
2.43 (±1.80)
× 105
2.49 (±1.70)
× 107
3.69 (±1.79)
× 107
6.49 (±5.97)
× 107
5.51 (±4.14)
× 107
9.10 (±3.74)
× 107
A. naeslundii 6.00 (±8.49)
× 101
4.00 (±5.66)
× 101
1.00 (±1.41)
× 101
2.80 (±1.70)
× 102
1.60 (±0.28)
× 102
1.40 (±0.57)
× 102
2.40 (±3.11)
× 102
P. intermedia 5.00 (±1.41)
× 101
5.00 (±1.41)
× 101
6.00 (±0.00)
× 101
4.00 (±2.83)
× 101
4.00 (±2.83)
× 101
3.00 (±1.41)
× 101
5.00 (±1.41)
× 101
S. sanguinis 9.49 (±1.65)
× 104
8.05 (±1.41)
× 104
1.39 (±0.59)
× 106
5.63 (±0.99)
× 105
3.15 (±1.63)
× 105
5.18 (±3.05)
× 105
4.40 (±1.71)
× 105
Universal 6.81 (±2.59)
× 107
3.48 (±2.22)
× 107
1.56 (±1.02)
× 108
1.72 (±1.08)
× 108
1.51 (±1.28)
× 108
1.30 (±0.83)
× 108
1.61 (±0.01)
× 108
Chlorhexidine
24h 48h 72h 96h 120h 144h 168h
F. nucleatum 5.28 (±8.28)
× 103
8.25 (±9.77)
× 102
2.05 (±4.10)
× 102
6.40 (±7.18)
× 102
6.00 (±6.37)
× 102
2.80 (±5.20)
× 102
5.05 (±4.71)
× 102
L. casei 3.60 (±5.80)
× 102
2.60 (±3.81)
× 102
6.50 (±13.0)
× 101
3.20 (±5.13)
× 102
2.60 (±3.59)
× 102
6.00 (±10.7)
× 101
3.15 (±3.00)
× 102
V. dispar 3.28 (±5.02)
× 105
4.05 (±5.69)
× 105
3.53 (±3.35)
× 105
4.86 (±2.24)
× 105
2.08 (±1.93)
× 105
7.02 (±7.24)
× 105
5.65 (±2.77)
× 105
N. subﬂava 7.91 (±10.0)
× 105
5.98 (±8.67)
× 105
4.80 (±4.91)
× 106
9.34 (±12.1)
× 106
6.95 (±7.91)
× 106
1.08 (±1.21)
× 107
7.97 (±4.94)
× 106
A. naeslundii 3.88 (±3.47)
× 101
1.15 (±1.92)
× 101
0.00 (±0.00)
× 100
1.50 (±3.00)
× 101
1.00 (±2.00)
× 101
1.50 (±3.00)
× 101
9.75 (±12.1)
× 100
P. intermedia 4.00 (±4.90)
× 101
4.00 (±4.32)
× 101
2.50 (±3.79)
× 101
5.50 (±5.26)
× 101
4.50 (±4.43)
× 101
2.00 (±2.83)
× 101
3.50 (±3.00)
× 101
S. sanguinis 7.41 (±8.43)
× 104
2.25 (±2.39)
× 104
5.75 (±6.38)
× 104
1.39 (±1.52)
× 105
7.38 (±7.62)
× 104
9.35 (±10.3)
× 104
2.01 (±1.69)
× 105
Universal 2.06 (±2.57)
× 107
1.49 (±0.47)
× 107
2.99 (±2.57)
× 107
5.01 (±1.91)
× 107
4.33 (±2.17)
× 107
6.75 (±4.92)
× 107
7.30 (±2.85)
× 107
LMW mushroom
24h 48h 72h 96h 120h 144h 168h
F. nucleatum 3.30 (±3.82)
× 102
5.40 (±2.26)
× 102
3.40 (±3.68)
× 102
3.10 (±2.12)
× 102
6.60 (±9.33)
× 102
3.40 (±3.96)
× 102
2.40 (±3.11)
× 102
L. casei 1.05 (±1.34)
× 101
5.10 (±3.54)
× 102
1.90 (±1.27)
× 102
5.00 (±7.07)
× 101
5.00 (±7.07)
× 101
7.00 (±9.90)
× 101
5.00 (±7.07)
× 10−1
V. dispar 8.05 (±11.2)
× 101
1.32 (±0.29)
× 104
6.73 (±0.05)
× 106
6.92 (±2.18)
× 106
1.46 (±0.65)
× 107
2.43 (±1.19)
× 107
2.35 (±1.09)
× 107
N. subﬂava 4.86 (±1.78)
× 105
2.20 (±1.40)
× 107
5.39 (±2.25)
× 107
7.10 (±3.29)
× 107
1.26 (±0.65)
× 108
1.40 (±0.83)
× 108
1.50 (±0.50)
× 108
A. naeslundii 0.00 (±0.00)
× 100
2.00 (±2.83)
× 101
2.20 (±0.57)
× 102
3.00 (±1.41)
× 101
0.00 (±0.00)
× 100
0.00 (±0.00)
× 100
0.00 (±0.00)
× 100
P. intermedia 1.00 (±1.41)
× 101
1.00 (±1.41)
× 101
1.00 (±1.41)
× 101
2.00 (±2.83)
× 101
3.00 (±4.24)
× 101
1.00 (±1.41)
× 101
2.00 (±2.83)
× 101
S. sanguinis 5.99 (±4.29)
× 104
8.67 (±3.87)
× 105
3.72 (±0.76)
× 106
6.36 (±2.07)
× 106
6.55 (±1.97)
× 106
5.99 (±2.97)
× 106
5.06 (±1.58)
× 106
Universal 4.60 (±2.56)
× 107
8.96 (±1.11)
× 107
1.98 (±0.69)
× 108
2.88 (±0.39)
× 108
3.80 (±1.04)
× 108
3.25 (±0.12)
× 108
2.75 (±0.59)
× 108Journal of Biomedicine and Biotechnology 5
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Figure 2: F. nucleatum, N. subﬂava, S. sanguinis, V. dispar, and total bacterial cell numbers which displayed signiﬁcant diﬀerences between
the diﬀerent treatments.
of dental plaque [35], A. naeslundii is only one species
representativeofthisgenus.Itislikelythattheenvironmental
conditions within the CDFF experiments were not optimal
for the above taxon, but other members of the genus may
have been present. Previous studies have found that L. casei,
S.mutans,andA.naeslundiiallgrowwellinbioﬁlmscultured
using saliva and the addition of a carbohydrate such as
glucose or sucrose [22, 36]. The lack of glucose or sucrose
in the culture media in the present study could account for
the low detection rates of these organisms. A previous study
has shown that Prevotella spp. were detectable in the CDFF
inoculum but not during the duration of the experiment6 Journal of Biomedicine and Biotechnology
using molecular methods [37], supporting the data from the
current study where the pathogen was detected at very low
levels throughout.
The organisms found in consistently high numbers from
the beginning of all of the experiments were N. subﬂava,
S. sanguinis, and V. dispar. All of these organisms have been
shown to be early colonizers during the formation of dental
plaque as well as being among the most abundant taxa in
the oral cavity [34, 35, 38]. F. nucleatum numbers increased
at a slightly later stage of plaque bioﬁlm formation once
the environmental conditions were optimal [39], as seen in
the NTC experiment designed to mimic conditions during
gingivitis.
Gingivitis is caused by the buildup of the plaque bioﬁlm
at the gingival margin, which in turn results in a shift in
the resident microbiota as a consequence of environmental
changes [4, 5]. The prevalence of Actinomyces spp., Lac-
tobacillus spp., Prevotella spp., and F. nucleatum is known
to increase during gingivitis at the expense of Streptococcus
spp. [6, 7, 9]. It was apparent that numbers of F. nucleatum
rose over time in the NTC experiment and that S. sanguinis
numbersdeclinedafteraninitialpeakat72hcoincidingwith
the F. nucleatum increase.
Looking at the treatment eﬀects, the application of chlo-
rhexidine signiﬁcantly lowered the numbers of N. subﬂava,
V. dispar,a n dF. nucleatum compared to NTC The total cell
numbers were also lower during the CHX treatment, no
doubt in part due to the lower numbers of the above taxa.
Chlorhexidine is considered the gold standard [24] in the
treatment of gum disease, and its action has been well stud-
ied. Previous studies looking at the eﬀects of chlorhexidine
onplaquebioﬁlmsinvitrohaveshownaneﬀectonVeillonella
sp., Fusobacterium sp., and Streptococcus sp. numbers [22,
25], supported by the current study. The MUSH treatment
signiﬁcantly lowered the numbers of F. nucleatum,a no r a l
pathogen, but also resulted in signiﬁcantly higher numbers
of S. sanguinis, normally associated with oral health, when
comparedtotheCHXtreatment.ThisincreaseinS.sanguinis
numbers despite the gingivitis conditions in the CDFF is
an important eﬀect. Furthermore, the MUSH treatment did
not have a negative eﬀect on N. subﬂava and V. dispar,b o t h
organisms associated with oral health [34, 38]. The data
presented in the current study are supported by previous
research which demonstrated the antimicrobial eﬀects of
shiitake mushroom products on a number of Gram-positive
and negative organisms including some oral pathogens [17,
40, 41].
Inconclusion,thecomparisonofthediﬀerenttreatments
using the CDFF has given a valuable insight into the com-
munity dynamics of dental plaque as well as an indication
of the eﬃcacy of the treatments. Chlorhexidine was found
to be eﬀective at lowering a number of taxa, associated with
both health and disease; however, shiitake mushroom extract
was shown to be eﬀective at reducing the numbers of the oral
pathogen F. nucleatum, while having little eﬀect on some of
the taxa associated with health. The results imply that the
action of shiitake mushroom extract should be investigated
further for its beneﬁcial eﬀects on oral health.
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